Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.92 USD | -0.86% | -11.40% | +69.61% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.55B |
---|---|---|---|---|---|
Net income 2024 * | -266M | Net income 2025 * | -277M | EV / Sales 2024 * | - |
Net Debt 2024 * | 10.59M | Net cash position 2025 * | 190M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.7
x | P/E ratio 2025 * |
-6.22
x | Employees | 328 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.37% |
Latest transcript on Sana Biotechnology, Inc.
1 day | +0.93% | ||
1 week | -11.59% | ||
Current month | -7.93% | ||
1 month | -8.66% | ||
3 months | -27.32% | ||
6 months | +89.70% | ||
Current year | +69.24% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Harr
FOU | Founder | 53 | 18-07-12 |
Nathan Hardy
DFI | Director of Finance/CFO | 48 | 18-08-31 |
Gary Meininger
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-09 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 20-04-30 | |
Patrick Yang
BRD | Director/Board Member | 75 | 18-09-30 |
Robert Nelsen
FOU | Founder | 60 | 18-07-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.03% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 6.92 | -0.86% | 2 359 514 |
24-06-07 | 6.98 | -5.16% | 1,124,266 |
24-06-06 | 7.36 | -6.00% | 1,124,019 |
24-06-05 | 7.83 | +4.40% | 1,083,979 |
24-06-04 | 7.5 | -3.97% | 1,070,184 |
Delayed Quote Nasdaq, June 10, 2024 at 03:51 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+69.24% | 1.55B | |
+49.11% | 57.87B | |
+41.65% | 40.25B | |
-6.65% | 39.94B | |
-5.96% | 28.54B | |
+13.07% | 26.4B | |
-19.75% | 19.33B | |
+32.13% | 12.4B | |
+0.11% | 12.23B | |
+25.14% | 12.2B |
- Stock Market
- Equities
- SANA Stock